AbbVie develops global patent portfolios related to SKYRIZI®
Client(s) AbbVie Inc.
Jones Day is representing AbbVie Inc. in the development and prosecution of global patent portfolios related to SKYRIZI®, an interleukin-23 (IL-23) inhibitor for treating inflammatory conditions.